Polypill in Australia within two years?

The polypill is back on the agenda – but this time for secondary prevention.

Australian researchers believe a polypill product will be available in Australia within two years, and they want it used by GPs to fix the ‘treatment gap’ for guideline-recommended therapies in people with cardiovascular disease.

Speaking at the World Congress of Cardiology in Melbourne this week, Ruth Webster of the George Institute for Global Health in Sydney said Australian trials had shown the polypill to be well accepted by both GPs and patients when used to  improve uptake of evidence-based